StockNews.AI
PFE
New York Post
146 days

Feds probe tip that Pfizer delayed announcing COVID vaccine's success until after 2020 election: report

1. Federal prosecutors are probing GSK's claims about Pfizer's COVID vaccine announcement delay. 2. GSK's former head claimed Pfizer delayed success announcement until after the 2020 election. 3. Philip Dormitzer disputed claims, stating they expedited FDA authorization efforts. 4. Trump previously accused Pfizer of withholding positive vaccine data without supporting evidence. 5. Investigators have interviewed GSK executives; Pfizer officials have not yet been contacted.

4m saved
Insight
Article

FAQ

Why Bearish?

Investigations into Pfizer raise concerns about its credibility and transparency, similar to previous issues affecting stock prices in the pharmaceutical sector when controversies arise. Historical examples include the impact on share prices of companies like Purdue Pharma during litigation concerning opioid crises.

How important is it?

The allegations and ongoing probe could directly undermine investor confidence in Pfizer, influencing the stock's immediate volatility.

Why Short Term?

The investigation's results are likely to be communicated soon, prompting immediate reactions in PFE stock.

Related Companies

Related News